Abstract Objective: The aim was to investigate the role that municipalities and out-patient health care centres (HCCs) have in understanding adherence to official guidelines on statin prescribing. Our hypothesis was that after guideline publication, adherence to recommended statin prescription would increase and variance among HCCs and municipalities would decrease. Since multilevel regression analysis (MLRA) is a relatively new methodology in pharmacoepidemiology, we also aimed to explore the application of MLRA in our investigation. Methods: We obtained data from the Swedish Corporation of Pharmacies record of sales regarding all initial prescriptions of statins issued between April and December 2003. We applied multi-level analysis on 34,514 individual prescriptions (level 1) nested within 226 HCCs (level 2), which in turn were nested within 33 municipalities (level 3). Temporal trends and gender differences were investigated by means of random slope analysis. Variance was expressed using median odds ratio (MOR) and interval odds ratio. Results: HCCs appeared to be more relevant than municipalities for understanding the physicians' propensity to prescribe a recommended statin (MOR HCC =1.96 and MOR Municipality=1.41). Overall prevalence of adherence was very low (about 20%). After publication of the guidelines, prescription of recommended statins increased, and variance among HCCs decreased but only during the first 4 months of the observation period. Conclusion: The publication of official guidelines in the county of Scania exerted a positive influence on statin prescription but, at the end of the observation period, adherence was still low and practice variation high. These facts may reflect inefficient therapeutic traditions and suggest that more intensive interventions may be necessary to promote rational statin prescription.
Introduction
The importance of appropriate prescribing for the wellbeing of the patient and for efficient use of limited health budgets cannot be exaggerated. Since 1997, every Swedish county has had a drug committee charged with promoting safe and cost-efficient drug use based on evidence-based medicine [1] . The committees aim to recommend medications appropriate to clinical needs, in doses that meet their patients' individual requirements, for an adequate period of time and at the lowest costs to the community [2] . The recommendations respect the patients' choices and strive to maximise effectiveness while minimising risks and costs [3] . However, despite the existence of formal committees and guidelines on appropriate prescription, it is still not known to what extent these criteria are being followed and which factors may condition adherence to guidelines [4] .
This study aimed to investigate variance among different municipalities and out-patient health care centres (HCCs) regarding adherence to guidelines on statin prescribing issued by the county council of Scania, Sweden, in March 2003. We wanted to investigate prescribing behaviour, and statins are an ideal medication group for this purpose since prescription of recommended statins is indicated for certain patients but not for others and since all statins have a similar efficacy (dependent on the particular dose used). We also analysed prescriptions rather than dispensations by the pharmacies because dispensations are conditioned by the pharmacist (e.g. with dispensation of generic drugs). Our hypothesis was that adherence to guidelines would result in increased prescription of recommended statins and decreased variance among HCCs and municipalities during the observation period. Moreover, since multi-level regression analysis (MLRA) is a relatively new methodology in pharmacoepidemiology, we also aimed to explore the application of this methodology for investigating practice variation. MLRA allows us to understand not only which patient, HCC and municipality characteristics are associated with adherence to recommended statins, but also the relative role of these different levels for successful adherence to prescription guidelines [5, 6] .
Materials and methods

The register of pharmacological agents
Using the Swedish Corporation of Pharmacies record of sales, we selected all 34,514 prescriptions (16,400 for women and 18,114 for men) of statins issued between April and December 2003 at 226 HCCs in the 33 municipalities of Scania. Statins were defined according to the Anatomical Therapeutic Chemical (ATC) classification system code C10AA. The current prescription guidelines in the county were published in March 2003 and we started our evaluation in April in order to allow a run-in period and exclude the initial short-term variation.
In the register, each prescription, regardless of number of drugs, is given a unique serial number. Among other data, the register records information about the brand name and ATC code for both prescribed and dispensed drugs as well as stating whether the prescription is a repeat prescription or not. Moreover, the register records the age and gender of the patient as well as the HCC where the prescription was issued. Prescriptions issued at hospitals, at unidentified places, at places outside Scania and by a prescriber with no agreement with the county council are not recorded in the database.
Though a prescription is valid for 1 year, the reimbursement system accepts a maximum of 3 months' supply per dispensation. Since we evaluated adherence to the prescription guidelines issued in March 2003, we investigated only those prescriptions that were issued after this date. Since dispensations are for 3 months, but prescriptions for 1 year, we selected initial prescriptions only in order to reduce the risk of analysing the same prescription twice. In practical words, a patient may get a prescription of a statin that covers a whole year. However, the rules say that you cannot get the whole year supply on one occasion, but every 3 months. For this reason, we only accounted for the first dispensation within the study period.
Variables
At the individual level, the outcome variable was prescription (yes versus no) of Simvastatin GEA or Pravachol, the two recommended brands in the county during the period of our analysis. By law, the Swedish Society of Pharmacies dispenses the cheapest alternative of equivalent drugs, if patient and doctor agree. Therefore, since the aim of our study was to investigate determinants of prescription rather than of dispensation, we performed our main analysis on prescribed drugs.
Age was centred on the mean age of 66 years. We created dummy variables to define sex, and every one of the five health care districts in the county (north-west, north-east, south-west, south-east and central) as well as for the administrative status (private versus public) of the HCC. Private physicians are less restricted by the public health care administration, which could be expressed in a lower adherence to county guidelines.
We considered time (in months) as a continuous variable (April=0, May=1, ..., December=8) that was modelled as a quadratic function. At the municipality level, we obtained the variable physician density, defined as number of physicians per 10,000 inhabitants in the 33 municipalities in Ska˚ne.
Statistical analysis
Multi-level logistic regression models
Because of the hierarchical structure of the data, with patients (first level) nested within HCCs (second level) which, in turn, were nested within municipalities (third level), we analysed the probability of prescribing a recommended statin by means of MLRA [7, 8] .
We applied three consecutive models. The first model (model A) only included the time variable. In the second model (model B), we included age and sex. In the third model (model C), we added the HCC-level variable private versus public HCC and the municipality-level variables physician density and health care district.
To study associations, we calculated odds ratios (ORs) and their 95% confidence interval (95% CI) from the regression coefficients and their standard error (SE) in the fixed-effects part of the multi-level analysis.
Ranking of HCCs
We compared the probability of prescribing a recommended statin in every HCC with the mean probability in the whole county and ranked the HCCs according to this information. To do this comparison, we obtained the posterior means (also called ''shrunken residuals'') from the multi-level regression. These residuals corresponded to the OR (logarithmic scale), using the whole county as reference [9] [10] [11] .
Variance, variance function and proportional change in variance
In the random-effects part of the multi-level analysis, we obtained the variance (SE) at the HCC and municipality levels. We calculated the proportional change in variance (PCV) between two consecutive models as follows:
where V 0 is the variance in the initial model and V 1 is the variance in the model with more terms.
We allowed the regression coefficients of the variables time and sex to be random at the HCC level (i.e. random slope analysis). In this way, we were able to investigate whether trends of gender-specific prescribing of recommended statins differed among different HCCs. In the presence of random slopes, the HCC variance becomes a function of the individual variables. We used standard applications available in the MLwiN software [12] for the calculation of the variance function. The formulas and an extended explanation are detailed elsewhere [13, 14] .
Examining local therapeutic traditions by means of MLRA
Since prescription of recommended statins depends solely on the arbitrary decision of the prescriber, it appears theoretically plausible to expect no significant variance among HCCs and municipalities in the prescription of recommended statins. However, if such variance existed, the tendency of prescribing a recommended statin may be more similar among prescribers within the same HCC and the same municipality than among prescribers from different HCCs and municipalities. This similarity (i.e. residual correlation, in statistical terms) would express itself as a clustering of prescriptions of recommended statins within HCCs and municipalities [10, 15, 16] . That is, a part of the individual propensity of prescribing a recommended statin would be at the HCC or municipality level. Our rationale was that this phenomenon is an expression of local therapeutic traditions and can be investigated by measures of variance and clustering in MLRA (see below).
We expected that possible local therapeutic traditions (i.e. unexplained practice variation) would decrease after the official guidelines were published in March 2003 and in this study we aimed to describe this variance.
The median odds ratio
Direct epidemiological interpretation of HCC and municipality variance in the logistic regression is difficult [7, 17] . One suitable alternative is calculating the median odds ratio (MOR), as proposed by Larsen and co-authors [8, 18] . The MOR translates the variance in the widely used OR scale, which has a consistent and intuitive interpretation. The MOR can be directly compared with the ORs of individual or area variables. In very simple terms, the MOR could be interpreted as the increased (median) probability of being prescribed a recommended statin if a patient was to change HCC (or municipality). The MOR depends directly on the HCClevel variance and can be computed using the following formula:
where V HCC is the HCC-level variance, and 0.6745 is the 75th percentile of the cumulative distribution function of the normal distribution with mean 0 and variance 1. If the MOR was equal to 1, there would be no differences among HCCs in the probability of prescribing a recommended statin. If there were important HCC-level differences, the MOR would be large.
The accuracy of the variance estimates was evaluated by their SE. We applied an approximate normal test for the calculation of P values. A P value >0.05 was considered non-significant (NS).
The 80% interval OR
Contrary to individual-level variables in multi-level models, area variables only take one value in each area and, consequently, it is necessary to compare individuals from different HCCs or municipalities to quantify area-level associations [19, 20] . Therefore, we need to incorporate the HCC/municipality variance in the presentation of area-level associations. For this purpose, we applied the 80% interval odds ratio (IOR-80), as described in detail elsewhere [8, 18, 20] . The lower and upper bounds of the IOR can be computed using the following equations:
where b is the regression coefficient for the hospital-level variable, V H is the hospital-level variance, and the values À1.2816 and +1.2816 are the 10th and 90th percentiles of the normal distribution, with mean 0 and variance 1 (see references for further explanation [8, 18, 20] ). It should be noted that the IOR-80 is not a common confidence interval. The interval is narrow if the residual variation between different HCCs is small and wide if this variation is large. If the interval contains the value 1, this indicates that the effect of the higher-level characteristic under scrutiny is not that important when compared with the remaining residual higher-level heterogeneity. The IOR therefore complements the information provided by the normal OR.
Parameters were estimated using the restricted iterative generalised least square (RIGLS) method. The analyses were performed using the MLwiN 1.2 software developed by Goldstein research group [12] . Table 1 indicates that the prevalence of adherence with guidelines for prescription of statins was overall 20% and this prevalence was the same for both men and women. The number of private HCCs was similar to the number of public HCCs in the whole county, but this figure was much lower in the north-east and central health care districts. Physician density was lower in the north-west and north-east health care districts than in the other three health care districts.
Results
In Table 2 , model A shows that factors related to the HCC and municipality level together played a relevant role in understating individual prescription of recommended statins (MOR Municipality-HCC =2.13). However, it appears that HCCs are more relevant than are municipalities in this context (MOR HCC =1.96 and MOR Municipality =1.41).
The ranking of the HCCs and municipalities regarding their prevalence of use of recommended statins relative to the overall prevalence in the county at the beginning of the study period (i.e. intercept residuals) is presented in Fig. 1 both before (model A) and after (model C) making adjustments. The differences among the municipalities disappeared after adjustment, but the picture for HCCs is different. Many HCCs changed position in the ranking but the dispersion around the mean was only slightly reduced after adjustments in model C. The PCV indicates that 75% of the differences among municipalities were explained by the individual and contextual characteristics included in model C. However, this percentage was only 3% in relation to variance among HCCs.
Table 2 also shows that there was a significant temporal trend in prescription of recommended statins. Overall, the trends follow a quadratic function that is illustrated in Fig. 2 (thick black line) , with a steeper slope at the beginning of the period that levelled off and even decreased at the end of the study period. This figure also shows that many specific HCC temporal trends differed from the overall trend in the county.
The probability of being prescribed a recommended statin increased for every year of age, although by a very low degree. Men demonstrated a lower probability than women of being prescribed a recommended statin but-as in the case of the temporal trend described above-this association differed in different HCCs. Because of the existence of significant slope variance in the association between prescription of recommended statins and both time and sex, the HCC variance became a function of these variables. This phenomenon is illustrated in Fig. 3 where we also show the effect of the adjustments performed in models B and C. Regarding municipality and HCC-level variables, Table 2 shows that the probability of prescribing recommended statins was similar in private and public HCCs. The IOR-80 was wide, confirming the low Compared with the north-west, the south-east health care district exhibited a higher adherence to the county's guidelines on statin prescription. However, in this case, the IOR-80 was also very wide, indicating the low importance of this variable for understanding differences in adherence to guidelines among HCCs.
Physician density-a municipality characteristic-appeared to play a role in improving adherence, but this association was U-shaped, with the lowest probability in the second tertile group. The IOR-80 was relatively wide but this variable may have some relevance for the implementation of prescription guidelines.
Discussion
We present a relatively new analytical approach for drug utilisation studies in pharmacoepidemiology. MLRA reveals the role of different levels for understanding drug prescription and utilisation [5, 6] . Hierarchical structures (e.g. patients nested within physicians in different HCCs nested within counties in different countries) are common in pharmacoepidemiology, and MLRA allows an appropriate analysis of hierarchical structures for both statistical and epidemiological purposes [5, 21] . In the present study, moreover of providing some extended methodological description of MLRA, we have proposed a model of analysis for investigating practice variation in general and adherence to statin prescription guidelines in particular.
We used the month of April 2003 as a starting point in our evaluation since guidelines were published in the middle of March. In April, each HCC and municipality has a specific level of prescription, and our hypothesis was that successful adherence with guidelines would convey increasing prevalence of use of recommended statins and decreasing variance between HCC and municipalities along the observation period. Therefore, adjusting for period of time (e.g. January, February and March) before the publication of the guidelines is less relevant for analysing trends in prevalence and variation during the observation period. Moreover, the investigation of the association between physician density and health care districts and adherence with guidelines can only be done after these guidelines were actually published in the middle of March. There are few therapeutic reasons for choosing a more expensive drug brand among several brands of similar efficacy. Nevertheless, this practice was fairly common in the county, and the MLRA revealed substantial practice variation that may reflect local therapeutic traditions which hindered prescription of recommended statins.
Adherence to guidelines seemed to a considerable degree to be conditioned by contextual factors at the HCC and municipality levels. Physicians from the same HCCs and from the same municipalities showed a similar propensity to prescribe recommended statins. In other words, HCC and municipality levels appear to bear a significant part of the prescriber's inclination to issue a recommended statin. This relative ''responsibility'' [6] for successful adherence to prescription guidelines was higher for the HCC than for the municipality level.
These results, illustrated in Fig. 3 , suggest that in some way the publication of the official prescription guidelines reduced the initial practice variation, from MOR close to 2 in April to MOR close to 1.5 in September 2003. Thereafter, practice variation increased slightly but never reached the heterogeneity observed at the beginning of the observation period.
It should be noted that some HCCs that showed relatively high adherence in April showed a clear decreasing trend during the study period. The reasons for this behaviour need be investigated in detail. Excluding the outlier with the highest adherence in April (Fig. 2) from the analysis decreased the HCC variance from 0.500 to 0.420 and increased the municipality variance from 0.132 to 0.158 but did not have a major effect on slope variance.
In this study, we did not have access to information at the physician level. A part of the HCC variation found could therefore in fact be physician variation [6, 22, 23] , an aspect we observed in the Skaraborg Primary Health Care Database containing information from general practitioners' medical records [24] .
Practice variation is a common phenomenon which need not necessarily be inappropriate but, rather, may reflect equivalent therapeutic traditions confronting a Fig. 1 Differences in adherence to guidelines on statin prescribing among municipalities (top) and health care centres (HCCs) (bottom) before (filled circles) and after (open circles) adjustments for age, gender, administrative status of the HCC (private versus public), and physician density in the municipality and health care district similar health problem [25] [26] [27] [28] . However, when the same pharmacological agent is available in different brands at very different prices and the prescriber chooses the expensive brand, it is relevant to investigate determinants for these prescription disparities in order to launch interventions promoting appropriate prescription [29] . In this context, statins are an illustrative group of pharmacological agents since they have concrete indications [30] . They are the first-hand choice for treatment of hyperlipidaemia in adults with a high risk of developing heart disease. Statins have been shown to be effective in primary and, more specifically, secondary prevention of coronary heart disease and ischaemic stroke [31, 32] . Since all statins have the same indication and only marginal differences in efficacy, there are no solid reasons why expensive brands should be prescribed in general and for some patients rather than others in particular.
The process of prescription includes a number of phases (identification of the health problem, decision to prescribe, choice of medication and decision to cease using specific therapy) and could be influenced at different levels (e.g. at the patient, prescriber, HCC or health care district level). However, very few studies have aimed to understand the relative importance of these different levels [6, 22, 23] . Therefore, the present investigation provides valuable and original information that could be of relevance for planning and evaluating interventions aimed to promote efficient and evidencebased prescription.
In this study, we were interested in investigating prescribing behaviour, and statins are an ideal medication group for this analysis. Prescription of recommended statins is not specifically indicated for certain patients to the exclusion of others. There is therefore no rationale for considering patient characteristics as confounder factors. Rather, the interest in these variables resides in understanding reasons for low adherence to prescribing guidelines. In the present investigation, we only considered basic individual variables such as age and gender; however, a study of determinants of adherence to guidelines may require a qualitative research methodology [33] .
We found a rather low prevalence of adherence with recommended statins. The main reason for the low use of recommended statins might be that the guidelines were very strict, including only Pravachol and Simvastatin GEA.
It is known that some non-recommended statins such as rosuvastatin have been the subject of safety concerns [34] [35] [36] . This fact may promote adherence to use of recommended statins over and above the guidelines. However, this external influence should have affected all the HCCs and municipalities and has therefore less relevance with regard to variance in adherence with guidelines.
Our empirical analysis found that-even if in a small degree-women showed a higher probability than men of being prescribed cheaper recommended statins. The reasons for this behaviour seem irrational but we do think the results raise an interesting question. Our epidemiological study suggests that it may be interesting to perform further investigation, such as a qualitative analysis, in order to obtain more information on the reasons for this prescribing behaviour.
We found that municipality physician density influenced adherence to prescription guidelines. In other words, adherence was lower when the physician density was in the middle tertile group. As far as we know, this subject has been rarely investigated in previous studies and deserves more attention.
MLRA has been successfully employed in a number of previous studies in the field [6, 22, 23, 37] and appears to be a useful epidemiological tool for investigating and quantifying medical practice variation. Consequently, MLRA may prove to be a useful tool for evaluating and planning interventions.
In conclusion, adherence increased and the variation decreased during the study period, which suggests that in some way the publication of the official prescription guidelines in the county had a positive influence on statin prescribing. However, at the end of the observation period, adherence was still low and practice variation high. These facts may reflect inefficient therapeutic traditions and suggest that more intensive interventions may be necessary to promote adherence to prescription guidelines [38] .
